Autoantibodies to CD4 in HIV type 1-exposed seronegative individuals

被引:35
作者
Burastero, SE
Gaffi, D
Lopalco, L
Tambussi, G
Borgonovo, B
DeSantis, C
Abecasis, C
Robbioni, P
Gasparri, A
Lazzarin, A
Celada, F
Siccardi, AG
Beretta, A
机构
[1] DIBIT, San Raffaele Scientific Institute, 20132 Milan, 58, Via Olgettina
关键词
D O I
10.1089/aid.1996.12.273
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of this study was to investigate the presence and the fine specificity of anti-CD4 autoantibodies in seronegative subjects sexually exposed to HIV-1. Anti-CD4 autoantibodies were previously detected in a fraction of HIV-1-seropositive individuals, Whole sera, purified IgG fractions, and supernatants of EBV-transformed lymphoblastoid cell lines were analyzed by means of ELISA, Western blot, and by competition assays using monoclonal antibodies with known fine specificities. Anti-CD4 antibodies were found in 6 of 18 individuals exposed to HIV-1 infection and who have been persistently seronegative. These antibodies inhibited HIV-1-driven syncytium formation, did not interfere with the CD4-gp120 interaction, and competed for CD4 binding with two of three anti-CD4 monoclonals with known fine specificities. Moreover, autoantibodies with the same fine specificities were found in the supernatants of oligoclonal EBV-transformed B cell lines derived from these individuals, At variance, in the HIV-1-positive patients included in our study, the anti-CD4 antibody response was directed to a broader panel of epitopes, including those involved in CD4-gp120 interactions. In conclusion, anti-CD4 antibodies specific for defined epitopes of the CD4 molecule are generated in the course of an early immune response to HIV-1 antigens in the absence of other signs of infection, as they can be detected by conventional methods, These autoantibodies may play a protective role either alone or in association with other cellular and humoral factors.
引用
收藏
页码:273 / 280
页数:8
相关论文
共 37 条
[21]  
LANGLADEDEMOYEN P, 1994, J CLIN INVEST, V93, P1297
[22]   THE ABILITY OF CERTAIN SIV VACCINES TO PROVOKE REACTIONS AGAINST NORMAL-CELLS [J].
LANGLOIS, AJ ;
WEINHOLD, KJ ;
MATTHEWS, TJ ;
GREENBERG, ML ;
BOLOGNESI, DP .
SCIENCE, 1992, 255 (5042) :292-293
[23]   USE OF URACIL DNA GLYCOSYLASE TO CONTROL CARRY-OVER CONTAMINATION IN POLYMERASE CHAIN-REACTIONS [J].
LONGO, MC ;
BERNINGER, MS ;
HARTLEY, JL .
GENE, 1990, 93 (01) :125-128
[24]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 C5 REGION MIMICS THE HLA CLASS-I ALPHA-1 PEPTIDE-BINDING DOMAIN [J].
LOPALCO, L ;
DESANTIS, C ;
MENEVERI, R ;
LONGHI, R ;
GINELLI, E ;
GRASSI, F ;
SICCARDI, AG ;
BERETTA, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (08) :2016-2021
[25]   NONCOVALENT COMPLEXES OF HIV GP120 WITH CD4 AND OR MABS ENHANCE ACTIVATION OF GP120-SPECIFIC T-CLONES AND PROVIDE INTERMOLECULAR HELP FOR ANTI-CD4 ANTIBODY-PRODUCTION [J].
MANCA, F ;
SERAVALLI, E ;
VALLE, MT ;
FENOGLIO, D ;
KUNKL, A ;
PIRA, GL ;
ZOLLAPAZNER, S ;
CELADA, F .
INTERNATIONAL IMMUNOLOGY, 1993, 5 (09) :1109-1117
[26]  
MARTIN L, 1994, AIDS, V8, P389, DOI 10.1097/00002030-199403000-00017
[27]  
MULLER C, 1993, IMMUNOLOGY, V79, P248
[28]   GENETIC-ANALYSIS OF MONOCLONAL-ANTIBODY AND HIV BINDING-SITES ON THE HUMAN-LYMPHOCYTE ANTIGEN CD4 [J].
PETERSON, A ;
SEED, B .
CELL, 1988, 54 (01) :65-72
[29]   HIV-SPECIFIC CYTOTOXIC T-CELL ACTIVITY IN AN HIV-EXPOSED BUT UNINFECTED INFANT [J].
ROWLANDJONES, SL ;
NIXON, DF ;
ALDHOUS, MC ;
GOTCH, F ;
ARIYOSHI, K ;
HALLAM, N ;
KROLL, JS ;
FROEBEL, K ;
MCMICHAEL, A .
LANCET, 1993, 341 (8849) :860-861
[30]   HIVGP120 ACTIVATES AUTOREACTIVE CD4-SPECIFIC T-CELL RESPONSES BY UNVEILING OF HIDDEN CD4 PEPTIDES DURING PROCESSING [J].
SALEMI, S ;
CAPOROSSI, AP ;
BOFFA, L ;
LONGOBARDI, MG ;
BARNABA, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06) :2253-2257